Life Science ApS: Financial statements 2021
CVR: 38453726
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Life Science ApS (CVR 38453726) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -1,956 and a net result of DKK -1,963 compared with DKK -3 the year before. Equity in the 2021 report amounted to DKK 15,606. The solvency ratio was 5%.
- Gross Profit
- DKK -1,956
- Profit/Loss
- DKK -1,963
- Equity
- DKK 15,606
- Total Assets
- DKK 309,654
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -2 t. | -2 t. | 16 t. | - |
| 2020 | - | 0 | -3 | -21 t. | - |
| 2019 | - | -843 | -843 | -21 t. | - |
| 2018 | - | -25 t. | -22 t. | -21 t. | - |
| 2017 | 0 | 0 | 0 | 1 t. | - |
Official annual report
Find more companies like Life Science ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
On October 6, 2021, the company changed its name from Life Science IVS to Life Science ApS.
Life Science ApS has published its annual report for 2020. Gross profit came to DKK 0, and the net result was DKK -3.
About Life Science ApS
Life Science ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Life Science IVS and FluoGuide IVS. The management consists of Andreas Kjær and Morten Albrechtsen. The company is owned by Andreas Kjær and WEXOTEC ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -11,459 and a net result of DKK -11,456 compared with DKK -822 the year before. Equity in the 2025 report amounted to DKK 151,200.